Key result
The "Chinese Lantern" biodegradable septal defect occluder demonstrated satisfactory positioning, excellent sealing, and complete endothelialization at 1 month in a swine model.
Why the study?
Does the 'Chinese Lantern' biodegradable septal defect occluder provide effective sealing and endothelialization in a swine ASD/PFO model?
Does the 'Chinese Lantern' biodegradable septal defect occluder provide effective sealing and endothelialization in a swine ASD/PFO model?
A novel fully biodegradable septal defect occluder demonstrated feasibility, effective sealing, and complete endothelialization at 1 month in a preclinical swine model.
Should not yet change ASD closure practice; leaves open translation of biodegradable occluders to humans.
OBJECTIVE: Atrial septal defect (ASD) is a general term used to describe an opening in the atrial septum that divides the two atria; unless the hole is occluded, it can give rise to serious complications. Given the need for percutaneous deployment for ASD or patent foramen ovale (PFO) occluders, all currently available devices are made of metals (specifically nitinol) and synthetic fabric. However, their permanent presence in the human body is not desirable due to the risks of long-term allergy, toxicity, and complications such as thrombus formation, device arm fracture, and nickel allergy. Once the hole is covered by a newly regenerated tissue, the device is no longer needed; thus it is ideal if the device is fully absorbed by the body when healing is completed. METHODS: The "Chinese Lantern" device is made of fully biodegradable polymers featured with a unique pull-fold mechanism. The device was inserted across the ASD/PFO model created on Yorkshire swines through a short sheath by hybrid open surgery. X-ray imaging, echocardiography, and postmortem histopathology were obtained during the 1-month follow-up study period. RESULTS: X-ray imaging showed that the devices were in satisfactory position and stable. Echocardiography showed that there is no shunting from the right atrium to the left atrium, indicating excellent sealing. The in vitro degradation study and postmortem explantation study confirmed that the devices have good integrity during the 1-month trial. Furthermore, the devices appeared to be completely endothelialized after 1 month. CONCLUSIONS: This work proves the feasibility of interventional closure of ASD or PFO with an innovative biodegradable device, which we call the "Chinese Lantern" for its symbolic design.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2011) studied Atrial septal defect (ASD) or patent foramen ovale (PFO). "Chinese Lantern" biodegradable septal defect occluder was evaluated on Device position, stability, sealing, and endothelialization. The "Chinese Lantern" biodegradable septal defect occluder demonstrated satisfactory positioning, excellent sealing, and complete endothelialization at 1 month in a swine model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: